Data / Form D filings / OptoVista Holdings, LLC
OptoVista Holdings, LLC: Form D filings
OptoVista Holdings, LLC, a biotechnology company in Washington, DC, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on September 25, 2026, reports $3.7 million sold of a $3.7 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O Tern Therapeutics, 1200 G STREET, NW Suite 800, Washington, DC, 20005
- Phone
- (703) 919-6983
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2036372
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | New notice | $3,727,518 | $3,727,518 | 7 | Sep 11, 2026 | sec.gov | |
| Sep 6, 2024 | New notice | $13,978,813 | $6,978,813 | $7,000,000 | 4 | Aug 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Michael Rosini | Executive Officer | |
| Alexander Bailey | Executive Officer, Director | |
| Christina Ohnsman | Executive Officer | |
| Steven Oliveira | Director | |
| Kerry Propper | Director |
Every Form D from the week of Sep 21, 2026 · All recent filings in District of Columbia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OptoVista Holdings, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.